In the basket of retail investors, the penny stock, Zomedica Corp. (NYSE: ZOM) has been in murky waters for quite some time now, with more than 33% decline in its share price, following the last earnings release in November. It seems that investors have turned bearish on this penny stock.  Though the stock had skyrocketed to a 52-week high at $2.91, there seems to be no catalyst to drive the stock to bounce back in recent times.   Notably, the CEO of Zomedica, Larry Heaton will discuss the company’s overview at the upcoming virtual H.C. Wainwright BioConnect 2022 Conference. It is scheduled for January 10-13, 2022.
https://www.tipranks.com/news/zomedica-buy-sell-or-hold?utm_source=advfn.com&utm_medium=referral
Zomedica (AMEX:ZOM)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Zomedica Charts.
Zomedica (AMEX:ZOM)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Zomedica Charts.